(NASDAQ: LNTH) Lantheus Holdings's forecast annual revenue growth rate of 3.62% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.89%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.86%.
Lantheus Holdings's revenue in 2025 is $1,520,653,000.On average, 6 Wall Street analysts forecast LNTH's revenue for 2025 to be $100,370,107,000, with the lowest LNTH revenue forecast at $99,387,047,593, and the highest LNTH revenue forecast at $100,950,913,020. On average, 5 Wall Street analysts forecast LNTH's revenue for 2026 to be $104,942,985,496, with the lowest LNTH revenue forecast at $96,075,732,537, and the highest LNTH revenue forecast at $111,346,538,461.
In 2027, LNTH is forecast to generate $116,190,577,624 in revenue, with the lowest revenue forecast at $104,717,788,875 and the highest revenue forecast at $124,225,310,223.